Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jul 1:107:169-177.
doi: 10.1016/j.exger.2018.01.002. Epub 2018 Jan 4.

Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to

Adriane Dallanora Henriques  1 , Andrea Lessa Benedet  2 , Einstein Francisco Camargos  1 , Pedro Rosa-Neto  3 , Otávio Toledo Nóbrega  4
Affiliations
Review

Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to

Adriane Dallanora Henriques et al. Exp Gerontol. .

Abstract

There is increasing evidence that a number of potentially informative biomarkers for Alzheimer disease (AD) can improve the accuracy of diagnosing this form of dementia, especially when used as a panel of diagnostic assays and interpreted in the context of neuroimaging and clinical data. Moreover, by combining the power of CSF biomarkers with neuroimaging techniques to visualize Aβ deposits (or neurodegenerative lesions), it might be possible to better identify individuals at greatest risk for developing MCI and converting to AD. The objective of this article was to review recent progress in selected imaging and chemical biomarkers for prediction, early diagnosis and progression of AD. We present our view point of a scenario that places CSF and imaging markers on the verge of general utility based on accuracy levels that already match (or even surpass) current clinical precision.

Keywords: Alzheimer; Biomarker; Cerebrospinal fluid; Diagnosis; Mild cognitive impairment; Neuroimaging.

PubMed Disclaimer

References

    1. Organization WH; Internacional AD, editor. Dementia: a public health priority. Switzerland: 2012.
    1. American Psychiatric Association APA. Diagnostic and statistical manual of mental disorders: DSM-5. 5. Vol. 2013 Washington, D.C: American Psychiatric Association; 2013.
    1. Services USDoHaH. 2014–2015 Alzheimer’s Disease Progress Report: Advancing Research Toward a Cure. National Institute on Aging; 2015.
    1. Blennow K, Dubois B, Fagan AM, Lewczuk P, de Leon MJ, Hampel H. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer’s disease. Alzheimers Dement. 2015;11(1):58–69. - PMC - PubMed
    1. Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, et al. Alzheimer’s disease. Lancet. 2016;388(10043):505–17. - PubMed

Publication types